모더나 "한국 정부와 백신 4천만 도즈 공급 논의"
U.S. biotech company Moderna has released a statement saying that its vaccinations in South Korea are expected to start in the second quarter of 2021.
It made the statement on Tuesday, after reaching an agreement with the government on Monday to supply at least 40 million doses of the vaccine, enough to inoculate 20 million people.
